{
    "2018-09-27": [
        [
            {
                "time": "",
                "orginal_text": "复星医药：第七届董事会第七十一次会议(临时会议)决议公告",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事会",
                        "决议公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "公告精选：高升控股遭立案调查 思特奇股东拟减持不超20.43%股份 减持股份",
                "features": {
                    "keywords": [
                        "高升控股",
                        "立案调查",
                        "思特奇",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "复宏汉霖撤回新三板挂牌申请 拟赴港上市",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "新三板",
                        "撤回",
                        "赴港上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "撤回新三板挂牌申请 复星医药控股子公司复宏汉霖拟赴港上市",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "新三板",
                        "撤回",
                        "赴港上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "布局智能手机超声成像仪 复星医药斥资1.06亿美元投资BNI",
                "features": {
                    "keywords": [
                        "复星医药",
                        "智能手机",
                        "超声成像仪",
                        "投资",
                        "BNI"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "[公告摘要]复星医药(02196.HK)：复宏汉霖撤回新三板上市申请并拟于港交所主板上市",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "新三板",
                        "撤回",
                        "港交所",
                        "主板上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "复星医药1.06亿美元投资BNI 布局智能手机超声成像仪",
                "features": {
                    "keywords": [
                        "复星医药",
                        "投资",
                        "BNI",
                        "智能手机",
                        "超声成像仪"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "复星医药：复宏汉霖撤回新三板上市申请 拟赴港上市 IPO融资异常",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "新三板",
                        "撤回",
                        "赴港上市",
                        "IPO",
                        "融资异常"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "股市快讯：午后生物制品走强 华兰生物涨逾7%",
                "features": {
                    "keywords": [
                        "生物制品",
                        "华兰生物",
                        "涨逾7%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药股集体大涨 机构揭秘打好四季度“反击战”的三条思路",
                "features": {
                    "keywords": [
                        "医药股",
                        "大涨",
                        "四季度",
                        "反击战"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "97个药品通过一致性评价 可能将放弃GPO？",
                "features": {
                    "keywords": [
                        "药品",
                        "一致性评价",
                        "GPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "北上资金成交额剧增 继续加仓白酒龙头",
                "features": {
                    "keywords": [
                        "北上资金",
                        "成交额剧增",
                        "白酒龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}